| Bioactivity | BN 50341 is an orally active anticalcic agent and a benzazepine derivative. BN 50341 decreases the in vivo electrically induced thrombus formation in rat or guinea-pig artery and can be utilized in cardiovascular research[1]. |
| CAS | 107550-66-3 |
| Formula | C32H41ClN2O4 |
| Molar Mass | 553.13 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Etienne A, et al. Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. Agents Actions Suppl. 1986;20:259-66. |
BN 50341
CAS: 107550-66-3 F: C32H41ClN2O4 W: 553.13
BN 50341 is an orally active anticalcic agent and a benzazepine derivative. BN 50341 decreases the in vivo electrically
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.